Preventive Medicine, Public Health & General Preventive Medicine · New York, NY
NPI
1215075908
Since 2007
Specialty
Preventive Medicine, Public Health & General Preventive Medicine
Code 2083P0901X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
75 Maiden Ln, Suite 1206
New York, NY, 10038
Phone (212) 995-6495
Groups this clinician bills Medicare through
Medicare paid, 2024
$659K
32,766 services
Medicare patients, 2024
337
Average age 68
Drug cost, 2024
$1.0M
6,802 prescriptions
Company payments, 2025
$2,379
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Chaim Y Mandelbaum was code J0588 (injection, incobotulinumtoxin a, 1 unit), 24,255 times for 53 patients. In total Chaim Y Mandelbaum billed 32,766 services in 55 codes, and Medicare paid $659K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-04-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0588 Injection, incobotulinumtoxin a, 1 unit | Office | 24,255 | 53 | $3.89 | $94K |
| 99214 Office E&M - Established | Office | 2,758 | 321 | $98.17 | $271K |
| G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 949 | 240 | $153.35 | $146K |
| 80307 Drug Tests | Office | 943 | 238 | $38.51 | $36K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 745 | 47 | $0.09 | $63.37 |
| 96365 Intravenous Infusion, Hydration | Office | 100 | 30 | $52.40 | $5,240 |
| 64616 Musculoskeletal | Office | 80 | 39 | $154.02 | $12K |
| 99213 Office E&M - Established | Office | 78 | 34 | $72.97 | $5,692 |
| 20610 Joint Injection | Office | 61 | 24 | $50.66 | $3,090 |
| 62323 Nerve Block Injection - Back | Office | 58 | 39 | $221.76 | $13K |
| 20552 Musculoskeletal | Office | 57 | 47 | $36.50 | $2,080 |
| 20611 Joint Injection | Office | 55 | 22 | $72.79 | $4,004 |
| J1030 Injection, methylprednisolone acetate, 40 mg | Office | 44 | 25 | $4.45 | $196 |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 43 | 23 | $0.10 | $4.19 |
| 64615 Musculoskeletal | Office | 41 | 20 | $129.44 | $5,307 |
By year: 2022 $927K for 42,400 services; 2023 $811K for 47,296 services; 2024 $659K for 32,766 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 949 | 240 | $153.35 | $146K |
| 80307 Drug Tests | 943 | 238 | $38.51 | $36K |
Medicare prescription drug claims, 2024
In 2024, the drug Chaim Y Mandelbaum prescribed most often to Medicare patients was Oxycodone-Acetaminophen (Oxycodone Hcl/Acetaminophen), with 596 prescriptions and refills. In total Chaim Y Mandelbaum wrote 6,802 Medicare prescriptions that cost $1.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 596 | 596 | 129 | $14K |
| Oxycodone Hcl Generic | 422 | 422 | 83 | $9,321 |
| Gabapentin Generic | 395 | 430 | 94 | $3,717 |
| Diclofenac Sodium Generic | 364 | 401 | 97 | $100K |
| Tizanidine Hcl Generic | 312 | 323 | 57 | $2,189 |
| Pregabalin Generic | 258 | 270 | 55 | $7,588 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 212 | 212 | 48 | $3,721 |
| Lidocaine Generic | 185 | 196 | 52 | $18K |
| Morphine Sulfate Er Morphine Sulfate | 176 | 176 | 34 | $8,450 |
| Oxycontin Oxycodone Hcl | 159 | 159 | 23 | $121K |
| Baclofen Generic | 155 | 169 | 43 | $1,738 |
| Ibuprofen Generic | 139 | 146 | 30 | $787 |
| Cyclobenzaprine Hcl Generic | 137 | 139 | 37 | $691 |
| Methadone Hcl Generic | 136 | 136 | 26 | $4,018 |
| Omeprazole Generic | 134 | 182 | 25 | $1,177 |
Brand drugs: 1,123 claims; generic drugs: 5,679 claims; opioid claims: 2,416.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Chaim Y Mandelbaum $2,379 ($2,379 in general payments such as food, travel and fees) from 14 companies. The largest payer was Salix Pharmaceuticals, a division of Bausch Health US, LLC with $442.
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 34 | $442 |
| Boston Scientific Corporation BSX | 12 | $391 |
| Pfizer Inc. PFE | 9 | $288 |
| Collegium Pharmaceutical, Inc. COLL | 16 | $274 |
| Abbvie Inc. ABBV | 10 | $218 |
| Axsome Therapeutics, Inc. AXSM | 4 | $204 |
| Azurity Pharmaceuticals, Inc. | 6 | $159 |
| Medtronic, Inc. MDT | 2 | $102 |
| Scilex Pharmaceuticals Inc. | 3 | $63.84 |
| Vertex Pharmaceuticals Incorporated VRTX | 2 | $53.53 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.